Ultrasound-Tuned Antimicrobial Hydrogel–Coated Urinary Catheters Reduce Catheter-Associated Urinary Tract Infection: A Randomized Controlled Trial
DOI:
https://doi.org/10.61919/8f4kj330Keywords:
Antimicrobial Coatings; Catheter-Associated Urinary Tract Infection; Hydrogels; Ultrasound Therapy; Urinary Catheters; Randomized Controlled Trial.Abstract
Background: Catheter-associated urinary tract infection remains a frequent healthcare-associated infection, largely driven by microbial adhesion and biofilm formation on catheter surfaces. Conventional antimicrobial coatings have shown inconsistent effectiveness because of passive release kinetics and declining activity over time. Objective: To compare catheter-associated urinary tract infection rates between ultrasound-tuned antimicrobial hydrogel–coated urinary catheters and standard uncoated silicone catheters. Methods: This prospective parallel-group randomized controlled trial enrolled 60 hospitalized adults requiring indwelling urinary catheterization for at least 72 hours. Participants were allocated equally to an ultrasound-tuned antimicrobial hydrogel–coated catheter group or a standard catheter group. The intervention group received daily low-intensity ultrasound activation, while both groups received standardized catheter care. The primary outcome was clinically assessed and microbiologically confirmed catheter-associated urinary tract infection. Secondary outcomes included urine colony count, time to infection onset, symptomatic infection, and adverse events. Results: Catheter-associated urinary tract infection occurred in 1/30 participants (3.3%) in the ultrasound-tuned hydrogel group and 5/30 participants (16.7%) in the standard catheter group, representing an absolute risk reduction of 13.4 percentage points and an estimated relative risk of 0.20. Mean urine colony count was lower in the intervention group (2.1 × 10⁴ ± 0.8 × 10⁴ CFU/mL) than in the control group (6.7 × 10⁴ ± 1.9 × 10⁴ CFU/mL; p = 0.01). No catheter-related or ultrasound-associated complications were reported. Conclusion: Ultrasound-tuned antimicrobial hydrogel–coated catheters were associated with reduced infection risk and bacterial burden during short-term inpatient catheterization.
References
1. Laganà A. Innovative strategies to counteract healthcare-associated infections (HAIs): antimicrobial properties of engineered materials for prosthetic use. 2024.
2. Kong C, Wang X, Li H, Zhou H, Yang L. Advanced antibacterial materials for the prevention of nosocomial infections. INano Res. 2024;3(2):97-108.
3. Duque-Sanchez L, Qu Y, Voelcker NH, Thissen H. Tackling catheter-associated urinary tract infections with next-generation antimicrobial technologies. J Biomed Mater Res A. 2024;112(3):312-335.
4. Mukherjee S, Patra D, Maity S, Haldar J. Advancements in antimicrobial biomaterials: new avenues to ameliorate wound infections and implant-associated infections. Curr Innov Sci. 2025;3(1):E2210299X314905.
5. Sharma S, Mohler J, Mahajan SD, Schwartz SA, Bruggemann L, Aalinkeel R. Microbial biofilm: a review on formation, infection, antibiotic resistance, control measures, and innovative treatment. Microorganisms. 2023;11(6):1614.
6. Amod A, Anand AA, Sahoo AK, Samanta SK. Diagnostic and therapeutic strategies in combating implanted medical device-associated bacterial biofilm infections. Front Microbiol. 2025;70(2):321-342.
7. Braem A, Kamarudin NHN, Bhaskar N, Hadzhieva Z, Mele A, Soulié J, et al. Biomaterial strategies to combat implant infections: new perspectives to old challenges. Acta Biomater. 2023;68(8):1011-1049.
8. Arunachalam K, Pandurangan P, Shi C, Lagoa R. Regulation of Staphylococcus aureus virulence and application of nanotherapeutics to eradicate S. aureus infection. Pathogens. 2023;15(2):310.
9. Ferreres G, Ivanova K, Ivanov I, Tzanov T. Nanomaterials and coatings for managing antibiotic-resistant biofilms. Antibiotics. 2023;12(2):310.
10. Khanda M, Seal P, Mohan AJ, Arya N, Boda SK. Antimicrobial peptides and their application to combat implant-associated infections: opportunities and challenges. Nanomaterials. 2025;17(17):10462-10484.
11. Marzaman ANF, Roska TP, Sartini S, Utami RN, Sulistiawati S, Enggi CK, et al. Recent advances in pharmaceutical approaches of antimicrobial agents for selective delivery in various administration routes. Pharmaceutics. 2023;12(5):822.
12. Fakher S. Metal-ion doped borate bioactive glasses: a novel direction in minimizing nosocomial infections and antibiotic resistance. 2024.
13. Sharma D, Gautam S, Singh S, Srivastava N, Khan AM, Bisht D. Unveiling the nanoworld of antimicrobial resistance: integrating nature and nanotechnology. Front Microbiol. 2025;15:1391345.
14. Alnsour AR, Daghmash RM, Masadeh MM, Alzoubi KH, Masadeh MM, Bataineh NH, et al. The pharmaceutical role of silver nanoparticles in treating multidrug-resistant bacteria and biofilms. Curr Pharm Des. 2024;20(4):471-494.
15. Selim HMRM, Gomaa FAM, Alshahrani MY, Morgan RN, Aboshanab KM. Phage therapeutic delivery methods and clinical trials for combating clinically relevant pathogens. Ther Deliv. 2025;16(3):247-269.
16. Omidiyan M. Innovative nanomaterials for biomedical applications: photothermal approaches for antimicrobial devices. Houston: University of Houston; 2023.
17. Fady M, Rizwana H, Alarjani KM, Alghamdi MA, Ibrahim SS, Geyer J, et al. Evaluation of antibiofilm and cytotoxicity effect of Rumex vesicarius methanol extract. Nat Prod Res. 2023;21(1):20220286.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Danial Aziz, Zarina Naz, Muhammad Ishaque Mujeeb Rehman, Muhammad Zakria, Muhammad Rizwan, Akif Saeed Ch, Syeda Hadia Qudrat (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
© The Authors. This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).
.png)
